Stealth Adapted Viruses Linked To Autism and Other Diseases
Posted on Mar 18, 2005
Ms. April Oakes, President of TAAP
Author: W. John Martin, M.D., Ph.D.
Source: The Autism Autoimmunity Project (TAAP)
A lot of effort and resources within the autism community have been misdirected. Consequently, the epidemic continues. I am very confident autism will eventually be recognized as having a viral cause. This delay will be lessened if parents simply consider the facts and sort through the political and economic agendas that bias what they are mainly being presented.
The important facts are:
1. The cellular immune system does not effectively recognize all viruses. Effective immune recognition is generally restricted to only a few viral components. For example cytomegalovirus (a type of herpesvirus) has nearly 200 proteins yet over 90% of the cytotoxic T cell immune response is directed to only 3 viral components. By a process called "stealth-adaptation" a virus can lose these critical components and yet can retain or regain the ability to cause cell damage. I have DNA sequence data confirming this mechanism. More importantly, I have directly observed animals inoculated with stealth adapted viruses. The animals become extremely sick with widespread tissue damage, including extensive damage to the brain. Yet there is no inflammatory response; the usual hallmark of an infectious process. I have seen similar brain damage in several patients from whom I have cultured cell damaging (cytopathic) viruses. Interestingly, the animals largely recover from their illness over time (discussed later).
2. Unlike other organs in the body, the brain is uniquely sensitive to virus induced cell damage. With other organs, there is an overall uniform function. This means that limited localized damage in one area of these organs can be easily compensated by increased activity elsewhere. The brain functions differently with specific functions localized to distinct areas. Damage in one area cannot, therefore, be easily overcome. An exception is when the virus induces an auto-immune response such as in Hasimoto's disease of the thyroid which is not uncommon among stealth virus infected patients. The other exception is cancer which only requires a single cell to go astray.
3. The big political block to my work came when I announced in 1995 that the prototype stealth-adapted cytomegalovirus was not of human origin, but was derived from the monkeys used to make live polio virus vaccines. I immediately notified FDA, CDC and Wyeth the manufacturer of live polio virus vaccine, but received a very cold reception. Adding to this block was the undisclosed study performed by FDA and Industry in 1972 showing that all of the African green monkeys being used for polio vaccine production were infected with simian cytomegalovirus (SCMV). FDA and Industry failed to disclose this finding not contemplating that viruses could cause chronic illnesses.
4. FDA recently did locate 8 licensed lots of polio vaccines released to the public in 1976. Three of the 8 lots have DNA of SCMV. FDA investigators say they cannot culture live virus from these lots, nor can they legally provide them for outside testing. in spite of this finding, FDA officials are still reluctant to follow up on my initial reports of stealth-adapted SCMV being isolated both from a patient with chronic fatigue syndrome and from a patient with a bi-polar manic depressive psychiatric illness.
5. It is technically difficult to culture stealth-adapted viruses because of a tendency for the cell damaging effect not to progress. The cultures undergo a repair process because of materials that accumulate in the culture fluids. I now recognize that these materials provide an alternative (non-mitochondria) source of cellular energy.
6. The polymerase chain reaction (PCR) can be used to detect some stealth-adapted viruses providing the small region being targeted by this reaction is conserved. Another difficulty with the PCR assay is that not all stealth-adapted viruses are derived from SCMV. Rather stealth-adaptation is a generic process that presumably can occur with all types of cytopathic viruses, e.g. EBV, HHV-6, HSV, etc.
7. An individual from Florida recently sent his own and his father's blood to an animal testing laboratory. He had the smarts to pretend to be a veterinarian and to request tests on supposedly monkey blood. The result came back PCR positive for SCMV. I visited the testing lab. and assured myself they were able to clearly exclude human, rhesus monkey and baboon CMV and that the result was indeed positive for SCMV. The infected patient notified CDC of the results. CDC simply concluded they could not culture virus from his blood and the issue has seemingly been dropped. I received a "legal request" from the patient to test his blood. It induced the characteristic cytopathic effect caused by stealth-adapted viruses..
8. The Florida example underscores the infectious nature of stealth-adapted viruses. The gentleman became infected during a trip and soon after returning home saw marked behavioral changes in his son. His father visited briefly and he too became sick. There are many examples of "family illnesses of presumptive infectious origin" including many families in which there is an autistic child. The gentleman has markedly improved on ACE products (discussed below).
9. I have previously performed several double blind studies comparing stealth virus cultures from patients with various illnesses, including autism, with blood samples from volunteer donating blood for transfusions. A clear distinction was seen with the vast majority of patients testing positive compared to 10-15% of blood donors. According to the terms of the approved study, I could obtain no information on the health of those blood donors who tested positive. The implication of a contaminated National blood supply was hard for Public Health authorities to accept. In late 2002 I was encouraged (instructed) not to perform any further clinical testing and to ensure my compliance the clinical testing laboratory license was suspended. The only exceptions allowed were for research and, as I have recently learned, if legally requested.
10. The research focus returned to the issue that if there was no effective immune recognition, how does the body cope with stealth-adapted viruses. The answer was in the cultures that showed complete healing if inhibitory materials were allowed to accumulate. I had previously noted unusual complex structures in the brain cells of humans and stealth-virus inoculated animals. The mitochondria which normally supply the cell with energy were markedly disrupted, yet the cells were still surviving. It appeared as if the complex structures, and the materials accumulating in the cultures, were providing an alternative (non-mitochondria) source of cellular energy. I called these structures alternative cellular energy pigments (ACE pigments). ACE pigments were experimentally shown to provide an auxiliary defense mechanism that is particularly relevant in defending against stealth-adapted viruses.
11. The importance of the ACE pathway has been convincingly demonstrated in the ease of therapy for conventional HSV oral and genital lesions. The ACE pathway in these lesions can be easily activated using a dye called neutral red followed by brief exposure to ultraviolet-A light. This approach also works well with shingles and post herpetic neuralgia and with genital warts caused by human papillomavirus. FDA was notified of these findings last October and are still trying to decide if they want to classify neutral red as a drug or as a medical device.
12. The obvious implication for autistic children is to activate and/or support the ACE pathway. I have been impressed with some preliminary responses and now want to see controlled studies. The current format for the herpes treatment is to have patients select a physician of their choice. The physicians are to evaluate the lesions before and the day after therapy. We can compensate the physician up to 0.00 from fees collected from participants willing to join an Institute of Progressive Medicine. I think we should do the same with autistic children.
13. It is clear that the pharmaceutical approach to many chronic illnesses has its limitations. The public needs to be better informed of developments outside the pharmaceutical industry. Good data need to be collected from well designed clinical trials.
14. I hope the foregoing will give a sense of optimism to parents struggling with autism and related illnesses. Research on stealth-adapted viruses has opened up a whole new approach to disease therapy. I would like to encourage individuals to visit the web site www.s3support.com and to consider participating in clinical trials as one of the bonuses of being a member of the Institute of Progressive Medicine . The web site has copies of various publications and supporting information.
15. Parents can also put political pressure on the system to begin to address autism as an unintended consequence of allowing cytomegaloviruses to contaminate polio vaccines. Infected parents are at risk of having autistic children. Such parents can be identified, but not if the Public Health system will not allow stealth virus testing or acquire the know-how to do this type of testing within their own facilities. Kind regards, W. John Martin, M.D., Ph.D.
Posted May 11, 2005
Thanks for your expression of concern about the very limited research support I am receiving. The real concern ought to be for autistic children and their families. It is disappointing to me that very few so called advocates for these children are willing to acknowledge the potential role of stealth-adapted viruses in causing autism. I used to think it was my responsibility to convince others of what appeared to me to be pretty obvious. That is, if autism is epidemic one should suspect an infectious cause. A role for stealth-adapted viruses was established in double blind culture studies attested to by well qualified individuals. Yet the data were not acted upon. When I offered to speak at a local meeting in Los Angeles, I was bluntly told “You are off message John;” meaning that I was not supporting mercury as the cause of autism and not advocating expensive laboratory tests or therapies with kick-backs to those willing to wheel and deal. As I mentioned in an earlier letter, it is truly disappointing when a speaker fresh from receiving a standing ovation by appreciative parents is seen conversing with colleagues on how to franchise a lucrative scheme for generating exorbitant incomes. I rarely receive requests from other investigators or patient advocates to help explain stealth-adaptation or the concept of an alternative (non-mitochondria) pathway of cellular energy. Conversely my requests for an overview of laboratory results to better understand how they influence therapy are met with resistance. Similarly, the actual response rates to the various therapies in terms of hard clinical data are rarely provided. I would like to see a vigorous movement among parents of autistic children to demand that their children and other family members be tested in Public Health facilities for infectious viruses. Whether they are called stealth-adapted or something else, it is not difficult to demonstrate their presence using methods that were published over a decade ago. Some of the viruses will undoubtedly be shown to have arisen from African green monkey simian cytomegalovirus. This is consistent with FDA's own data of DNA of this virus being present in 3 of 8 licensed polio vaccine lots released in the mid 1970s. It also follows the 1972 realization that the monkeys being used to produce live polio virus vaccine were uniformly infected with simian cytomegalovirus. In retrospect, the use of freshly cultured monkey kidney cells to produce polio vaccines may turn out to be the biggest Public Health blunder of the last century. Stealth-adaptation of cytomegalovirus and other viruses is based on the simple concept that the cellular immune system only recognizes and reacts to relatively few viral components. In the case of human cytomegalovirus, over 90% of the anti-virus cytotoxic T cells are directed at only 3 of the nearly 200 different components. Loss or mutation of these critical components can allow a virus to evade effective immune recognition. A present day analogy is that of a terrorist who has no insignia or other means of identification. Like a terrorist, stealth-adapted viruses can still cause a lot of damage. It is mostly reflected by impaired functioning of the brain which is especially vulnerable to even limited localized cell damage. Fortunately, the immune system is not the only defense humans and animals have against virus infections. >From the beginning of the research, it was apparent that if cultures of stealth-adapted viruses were left undisturbed, the damaged cells would recover. The recovery process was attributed to the accumulation of what I termed alternative cellular energy pigments (ACE pigments). Validation of this approach has come from recently published studies showing expedited healing of conventional herpes simplex and herpes zoster viruses and also papillomavirus induced skin lesions by activating the ACE pathway. I firmly believe that autism will also be amenable to this type of approach. ACE related therapies are not dependent upon there being an underlying virus infection. On the other hand, mobilization of Public Health resources in support of preventing and treating autism will be more forthcoming to counter an infectious process. I am open to suggestions and to offers of help to move the process forward. This has been a productive year in terms of publications with five peer reviewed articles, four of which are on the web site www.s3support.com. The article that I look forward to seeing published this year will be one showing marked clinical benefits in autistic and other stealth-adapted virus infected children in response to activation of the ACE pathway. With sufficient support and public awareness, I feel this goal can be achieved. Kind regards, W. John Martin, M.D., Ph.D. Posted May 15, 2005 Dear April I received several enquiries in response to your posting a letter that I had recently sent. Among the questions being asked is why does CDC not believe in stealth-adapted viruses and why was I prohibited from continuing to perform stealth virus testing within the Center for Complex Infectious Diseases. The CDC has plenty of justification to test for stealth-adapted viruses but not the political will (meaning direction from Congress) to do so. The basic challenge “If autism is epidemic, why not look for an infectious cause?” has never been vigorously pursued by public health authorities. Your readers may be interested in the following vignette. Last year an individual developed an apparent infectious disease during a business trip. He initially feared AIDS in spite of there being no close sexual encounters. HIV tests were uniformly negative. His concerns about being infectious increased when he noted marked behavioral changes in his son. His father also started to experience headaches, fatigue and memory loss following a weekend visit. Having read of my work on simian cytomegalovirus (SCMV), he inquired of the Miami Zoo how they test for SCMV. They referred him to a primate testing laboratory that performs polymerase chain reaction (PCR) assays for various viruses. Having the smarts to adopt the name of his neighbor's dog for his own blood sample and a similar monkey sounding name for his father's blood, he requested testing from the primate laboratory. Both results came back positive for SCMV by PCR. I visited the laboratory and was assured of the positive results that excluded human, rhesus monkey or baboon CMV. Using the loophole that forensic testing is exempt from the Clinical Laboratory Improvement Act (CLIA) prohibition against unapproved clinical tests, I confirmed, in response to a formal legal request, that the individual was culture positive for a stealth-adapted virus. CDC was contacted by the individual. They did at least request blood and throat samples but did not avail themselves of my offer to describe how best to culture for stealth-adapted viruses. Not getting a positive culture, CDC readily dropped the ball. The individual has significantly benefited from products that can provide support through the alternative cellular energy (ACE) pathway. There are many other compelling reasons why CDC should be more proactive in pursuing the potential of widespread SCMV infection in the community. FDA has published data showing that 3 of 8 licensed polio vaccines released to the public in the mid 1970's contained DNA of SCMV. Congenital infection with regular human cytomegalovirus is one of the known causes of autism, being all the more reason to look for stealth-adapted cytomegalovirus. SCMV has multiple copies of a gene that enhances the infectivity of HIV. CMV is also implicated in major vascular diseases and in several forms of cancer. Various autism support organizations have been remiss in disregarding a potential infectious process as a major cause for the autism epidemic. More than once I have heard it argued “We don't want to go there less we give our children a pariah status.” More likely, the notion of an infection conjures an image of high fevers, inflammation and person to person transmission of an illness. None of these apply to autism. Nor do these parameters apply to stealth-adapted viruses that avoid effective immune recognition and do not provoke an inflammatory reaction. I have also been personally criticized by a few individuals who seem to need a focus for their anger. Negative comments, especially when presented on the internet have assuredly discouraged others from supporting my research and have played into the hands of those not wanting to face the reality of stealth-adapted viruses. In response to being asked once again to respond to such criticisms, I provided one of your readers with the following historical account. I thought it might be useful for you to share it with other readers. Kind regards, John. Dear Mr. ________, I have become pretty immune to pointless criticisms and feel it is part of the territory of working on a socially complex set of illnesses. An early encounter with patient anger came at a talk I gave at the University of Southern California (USC) in August 1994. I had just published an extensive article in the American Journal of Pathology that was entitled “Cytomegalovirus-related sequences in an atypical cytopathic virus repeatedly isolated from a patient with the chronic fatigue syndrome.” A husband and wife team of prominent academics from a major neighboring academic institution were in attendance at my talk. The data were straightforward and worth discussing. Instead the tenor of repeated interruptions from the husband was along the lines, “I have chronic fatigue and I am smarter than you. I do not know what causes it, neither do you.” Rather than leaving it at that, he complained to the dean who subsequently lectured me on how the University fund raising efforts could be undermined if I pursued divisive research. There was also a hostile backlash from some prominent researchers within the chronic fatigue and immune system dysfunction syndrome (CFIDS) community. They had looked for viruses but had either not found any or had dismissed what they saw as reflecting secondary reactivation. Again, I was surprised by their complaints going to the dean at USC. A CFIDS support group had earlier wanted there to be a correlation between a positive virus culture and the symptom of fatigue. When this was not true they also withdrew support in favor of more politically connected supporters. The research continued and by 1995 I had unequivocally established that at least two of the virus isolates were derived from the cytomegalovirus of African green monkeys. These results were published in an article appearing in July 1995 entitled “African green monkey origin of the atypical cytopathic 'stealth virus' isolated from a patient with chronic fatigue syndrome.” The same year I published a research letter “Stealth virus isolated from an autistic child” and a compelling paper along with Dr. Tom Glass entitled “Acute encephalopathy induced in cats with a stealth virus isolated from a patient with chronic fatigue syndrome.” The clinical and microscopic observations made in the cats paralleled those I had seen in severely ill patients with undiagnosed neurological diseases. There was subtle but extensive cell damage without any inflammation, the accepted hallmark of an infectious process. As far back as 1990, I had seen brain biopsies with no inflammation yet microscopic indications of the same type of cellular damage as was occurring in cultures from the blood and cerebrospinal fluids from chronic fatigue syndrome patients as well as from several children with autism and related illnesses. Moreover, the brain tissue yielded evidence for a virus infection using the polymerase chain reaction (PCR) assay. Several of the cultures showed electron micrographic evidence of virus activity along with peculiar material that I had initially discounted as cellular debris. I soon came to realize that this material was actually helping the cultures overcome the cell damaging effects caused by the viruses and knew that it might provide a clue on how to eventually treat patients infected with these viruses. I called these materials Epione after the wife of Asclepius, the father of Greek medicine. The African green monkey origin of some of isolated stealth-adapted viruses implicated live polio virus vaccine produced in kidney cell cultures from these monkeys as the probable source. Having worked at the FDA Bureau of Biologics, I was well aware of the vaccine production method and the continuing concerns about virus contaminants. My notifications to FDA, CDC and the vaccine manufacturer were not kindly received. Moreover, my offers to test chronic fatigue syndrome patients for evidence of monkey virus infection exceeded the threshold at USC. My laboratory was closed within a week of a lawyer filing a suit against the polio vaccine manufacturer for me to test some of the bulk lots of vaccines received by his ill clients. Having seen numerous examples of virus culture positive patients struggling with their illnesses, I was unwilling and indeed unable to sign an agreement with USC not to test any additional patient samples. The research proceeded quietly and at a slow pace in a private largely self-supported laboratory. At critical times an occasional person appeared who helped bridge a critical financial gap. I once called a Japanese donor who had provided some steady support to express my deep appreciation. His simple answer “It is my duty,” reinforced my own conviction that I was obligated to proceed with the research. In 2003 I again crossed a threshold by stating that up to ten percent of students donating blood to the UC Irvine Blood Bank were stealth virus positive. This brought into question the safety of the nation's blood supply. Of several hundred patient contacts, all but a few have been very rewarding and have more than encouraged my continuing efforts on their behalf. I have encountered the occasional hostile patient with a sense of anger, resentment, self-entitlement and betrayal when I have not endorsed an unjustified demand. One such patient was used by the California Department of Health to carry out the wish of the Centers for Disease Control and Prevention (CDC) to stop patient testing for stealth-adapted viruses. This was achieved by suspending a Clinical Laboratory Improvement Act (CLIA) laboratory license in September 2002. Copies of my fruitless letters to the Centers for Medicare and Medicaid that issues CLIA licenses are included on the web site www.s3support.com Fueled by the suspension of the CLIA license, the patient went on to file legal suits and make extraordinarily disparaging claims in a television interview. While I answered many leading and insulting telephone questions from a reporter from NBC, I chose not to grant her a filmed interview. My experience at USC had convinced me that major news organizations were unlikely to fairly air an opinion that polio vaccines were a potential source of many of today's epidemic illnesses. The bad publicity from the television showing was used by a splinter CFIDS group to declare on the internet that all stealth virus-related research was bogus. I have similarly been criticized for not endorsing various co-infections of patients with pathogens such as mycoplasma, HHV-6, Borrelia (the bacterium that causes Lyme disease) or with toxins, such as mercury in the case of autism. The criticisms have only come after an overture for me to join in and share a piece of their pie. I am more comfortable staying with what I know to be true. Viruses do exist that are not effectively recognized by the immune system. These viruses can be frequently cultured from patients with chronic debilitating neurological illnesses. Some of these viruses were unequivocally derived from the cytomegalovirus of the monkeys used to produce live polio virus vaccines. That the body can use a non-immunological defense mechanism to provide an alternative (non-mitochondria) source of cellular energy; and that this alternative cellular energy (ACE) pathway explains the repair process seen in cultures of stealth-adapted viruses. This pathway offers a promising approach to therapy of stealth-adapted viruses as well as an adjunct approach to therapy of conventional viruses such as herpes simplex, herpes zoster and human papillomavirus infections. Five papers have been submitted or published this year with several more in preparation. The research is providing interesting insights into basic biology and has important therapeutic and public health ramifications. It could benefit from more support and less criticism. I trust this answers your concerns.
Kind regards, W. John Martin, M.D., Ph.D.
Posted Oct. 22, 2005
I was helping someone prepare for an upcoming
interview by providing answers to possible questions. I am happy to
share the material with members of TAAP.
Is there evidence that the increasing prevalence of chronic illnesses
has an infectious and, therefore, transmissible, contagious component
and, if so, why is it not being recognized. Answer. There is an
inadequacy of epidemiological methods to identify an infectious
process causing chronic multifaceted diseases. An infectious process
is consistent with the patterns of family illnesses and with larger
What type of infection do you think is the probable cause of these
diseases: Answer. Cell damaging viruses that can cause a persisting
illness, explained in part by the inability of the immune system to
effectively recognize viruses that have deleted or mutated genes
coding for the relatively few viral components targeted by the immune
system. (A process that I have called stealth-adaptation). These
viruses can be cultured and can cause disease in animals.
Where have some of these stealth-adapted viruses come from. Answer.
African green monkey simian cytomegalovirus SCMV. (CMV is a type of
herpes virus). Published evidence from FDA of SCMV contamination of
polio vaccines produced in kidney cell cultures from African green
monkeys. Stealth-adaptation can potentially occur with any type of
cell damaging virus.
If the immune system does not respond to stealth-adapted viruses, how
is it possible for the body to control an infection. Answer. The body
uses an auxiliary defense mechanism whereby cells acquire needed
energy from an alternative (non-mitochondria) cellular energy
pathway. This pathway involves the conversion of physical energies
into cellular energy by materials I have called alternative cellular
energy pigments. Activation of these pigments can have therapeutic
benefits, as can providing products with ACE activity.
Some stealth-adapted virus infected patients release ACE pigments in
perspiration and from skin lesions. Patients mistake them for
parasites and can be labeled as having delusional parasitosis. Other
stealth-adapted viruses can assimilate bacterial sequences leading to
positive assays for various types of bacteria, including Borrelia
(the cause of acute Lyme disease), mycoplasma (a suspected cause of
Gulf War Syndrome).
Ongoing emphasis is on controlled clinical trials. Striking benefits
were seen with therapy of conventional herpes simplex and herpes
zoster virus infections. Energy based therapy also markedly improved
outcome of children with tropical diahhrea (study done in El Salvador
to be presented at the American society of Tropical Medicine and
Hygiene Meeting in New York, December 15, 2005).
What is CDC's position on stealth-adapted viruses. Answer. They are
unwilling to test for these viruses and hide behind the argument that
others have not confirmed their existence. In fact, there are data
supporting the underlying concept from several recent studies. CDC
has been notified on individuals testing positive for SCMV using the
polymerase chain reaction (PCR). Some of those working at CDC are
aware of the Public Health consequences of acknowledging
stealth-adapted viruses. Unfortunately, they are not in a position of
Why did you stop testing for stealth-adapted viruses. With input from
CDC, our license for testing for these viruses was suspended by the
Government in late 2002. All of the methods have been published and
provided to Public Health authorities. It is really their
responsibility to pursue infectious causes of diseases. Now that
potential therapies have been developed, one would hope for more open
communication. This will likely occur through public pressure on
Congress. I feel sorry for patients who have been led into thinking
that stealth-adapted viruses do not exist. Instead of a major Public
Health endeavor to control these infections, the emphasis has gone to
politically less challening explanations such as mercury causing
autism, depleted uranium causing Gulf War Syndrome; toxins causing
chronic fatigue; Borrelia causing so called chronic Lyme disease,
etc. Simple testing by Public Health authorities would confirm the
existence of stealth-adapted viruses; some of which or
iginated from the cytomegalovirus of African green monkeys
Is more information available on a web site. Yes the address is
Would additional financial support help in pursuing stealth viruses,
ACE pigments and clinical trials. Answer. Yes. The Center for
Complex Infectious Diseases is part of S3Support, a Public 501(c)
Charity. Donations are always welcome. Funding would also help with a
nationwide movement towards more rational allocation of health
resources. There are structural flaws in both orthodox and
complimentary/alternative approaches to medeical care. I am using the
term Progressive Medicine as a framework to incorporate energy based
I hope this information is helpful. Kind regards, W. John Martin, M.D., Ph.D.
Posted November 4, 2005
to come Posted November 10, 2005
I was pleased to informally explain the "stealth-adapted virus cause of autism" to a few attendees at the recent DAN conference. Included were a presenter whose child had improved on anti-viral therapy and a self proclaimed autism celebrity. I also spoke briefly with Mr. David Kirby, author of "Evidence of Harm." The DAN organizers have certainly heard about stealth-adapted viruses but for whatever reason the topic was again considered not suitable for public presentation. "What we decide to present is decided by a committee" someone told me and "they do not want to go there." Possibly it is to avoid controversy. More likely, many of the acknowledged experts are not really confident virologists. It is easier for them to grasp and communicate mercury contamination, biochemical pathways or gastrointestinal problems than to discuss atypical viruses. There is also a business aspect with vendors and clinicians struggling to make a living out of autism. My trying to ta lk science was not uncommonly interrupted with such comments as "I'm not making nearly enough as I should in my practice" or "Of course I'm entitled to make money by ordering laboratory tests or profiting from prescribing overpriced questionable supplements and therapeutic procedures." There are certainly conscientious DAN doctors, some of whom are themselves and/or have family members afflicted with neuropsychiatric illnesses. These physicians, in particular, should be speaking up against the obvious exploitation of parents by some of their colleagues. They should also be pushing the organizers for a more open discussion of stealth-adapted viruses as the cause of autism; even thought this issue may be less amenable to making money than the scientifically unfounded concepts currently being hyped. On a more positive note, I was able to recount the success of using an energy based product in children in El Salvador with severe diarrhea. Worldwide, this is a disease that kills at least 10,000 children every day. The data will be presented at an American Society of Tropical Medicine and Hygiene meeting next month. I am hoping to get FDA approval for the use of the product in the United States. Again, I am facing a series of hurdles, this time protective of the pharmaceutical industry, as opposed to concerns regarding the economic welfare and status of supposedly autism experts. The real tragedy is that by not discussing autism as a disease caused by atypical stealth-adapted viruses, there is no imperative for major Governmental intervention. The requested Government expenditure of over $7 billion dollars for a possible flu pandemic illustrates the intensity of concern raised by infectious diseases that can act indiscriminately throughout society. I would appreciate if you could again ask parents in TAAP and other autism support groups to simply request CDC testing of autistic children for stealth-adapted viruses. In the interim, I will try to expedite the process of having an effective energy based product brought into the country. Kind regards, W. John Martin, M.D., Ph.D.
Many thanks, John Martin
Posted by TAAP Nov. 23, 2005
Thank you for assisting me by directly contacting parents of autistic children. As we discussed, a concerted parent-based effort is needed to compel Government health authorities to examine autistic children for stealth-adapted viruses. To date, the Centers for Disease Control and Prevention (CDC) has avoided using published protocols for culturing stealth-adapted viruses. Simply stating that others have not replicated research on these viruses is an inadequate excuse for CDC not pursuing the epidemic of autism as an infectious disease. Having visited CDC on several occasions, I am convinced a better approach is to have the request for testing come directly from a Congressman or Senator. Politicians are answerable to their constituents but to date they have not heard about stealth-adapted viruses. Parents need to identify someone in Congress who is willing to set up an informal meeting attended by myself and a virologist from CDC. I believe I can do the rest.
I will be in Washington in mid December for a meeting of the American Society of Tropical Medicine and Hygiene. I will present data showing expedited recovery from infectious diarrhea in children in El Salvador who received an energy replenishing formulation. Progress in applying this type of therapy to autistic children will be greatly facilitated once autism is recognized as an atypical viral illness. Moreover, efforts can be made to identify children at risk for autism on the basis of being infected as newborns.
The issue for parents to convey to their representative is that the failure of CDC to test autistic children for stealth-adapted viruses is inexcusable especially since some of these viruses arose from cytomegalovirus of the monkeys used to produce polio vaccines. It can be further pointed out that several licensed batches of polio vaccines have been shown to contain DNA of African green monkey simian cytomegalovirus. Testing has to include the culture methods shown to be effective in detecting stealth-adapted viruses. I have done these cultures in autistic children and know that the results will be positive. It is long overdue for CDC to step up to the plate and either do the testing or explain to a politician why they choose not to do so.
Hopefully through cross-posting this request will rapidly reach a majority of parents with autistic children. I would appreciate receiving copies of any responses received from Government officials. A suitable e-mail for this purpose is firstname.lastname@example.org Information on stealth-adapted viruses is available at www.s3support.com Kind regards, W. John Martin, M.D., Ph.D.
It might be best to put it at the top and to work backwards according to date. Of more importance, some of the paragraphs in some of the TAAP letters are wrong. It is easy to spot them. Could you please bring have the fonts matching. Thanks for getting it done today.
Happy thanksgiving, John.